Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The reconstitution and administration of injectable medicines in the UK must be performed by, or under the direct supervision of, a qualified healthcare professional, following the product's SmPC and in accordance with NHS and NPSA guidance on the safer use of injectable medicines
Potential risks include: Infection risk if injections are administered in non-clinical settings without appropriate sterile technique Allergic reactions to any component of the formulation Liver toxicity theoretical concern with excessive methionine or choline Drug interactions particularly if combined with other supplements or medications Unknown long-term effects due to absence of longitudinal safety data The MHRA advises caution with unlicensed injectable products, as quality, purity, and sterility cannot be guaranteed
Week 1-2 Initial tissue healing response begins Week 2-4 Visible skin improvements may begin Week 4-8 Collagen synthesis and regeneration effects Week 8-12 Peak effects
Cagrilintide is a synthetic peptide analog of amylin
Description BPC-157, an abbreviation for Body Protection Compound-157, derives from body protection compound (BPC), a protein naturally occurring in the human digestive tract
US$ 27.52
US$ 27.06
US$ 25.99
US$ 22.17
US$ 28.64
US$ 27.73
US$ 29.33
